A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis.


Journal

Annals of hematology
ISSN: 1432-0584
Titre abrégé: Ann Hematol
Pays: Germany
ID NLM: 9107334

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 13 01 2020
accepted: 25 04 2020
pubmed: 8 5 2020
medline: 25 8 2020
entrez: 8 5 2020
Statut: ppublish

Résumé

Vasculopathy is a hallmark of sickle cell disease ultimately resulting in chronic end organ damage. Leg ulcer is one of its sequelae, occurring in ~ 5-10% of adult sickle cell patients. The majority of leg ulcer publications to date have emanated from single center cohort studies. As such, there are limited studies on the geographic distribution of leg ulcers and associated risk factors worldwide. The Consortium for the Advancement of Sickle Cell Research (CASiRe) was formed to improve the understanding of the different phenotypes of sickle cell disease patients living in different geographic locations around the world (USA, UK, Italy, Ghana). This cross-sectional cohort sub-study of 659 sickle cell patients aimed to determine the geographic distribution and risk factors associated with leg ulcers. The prevalence of leg ulcers was 10.3% and was associated with older age, SS genotype, male gender, and Ghanaian origin. In fact, the highest prevalence (18.6%) was observed in Ghana. Albuminuria, proteinuria, increased markers of hemolysis (lower hemoglobin, higher total bilirubin), lower oxygen saturation, and lower body mass index were also associated with leg ulceration. Overall, our study identified a predominance of leg ulcers within male hemoglobin SS patients living in sub-Saharan Africa with renal dysfunction and increased hemolysis.

Identifiants

pubmed: 32377816
doi: 10.1007/s00277-020-04057-8
pii: 10.1007/s00277-020-04057-8
pmc: PMC7430152
mid: NIHMS1605835
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2073-2079

Subventions

Organisme : NIMHD NIH HHS
ID : T37 MD001425
Pays : United States
Organisme : NIMHD NIH HHS
ID : 5T37MD001425-19
Pays : United States
Organisme : NIMHD NIH HHS
ID : 5T37MD001425-19
Pays : United States

Références

Br J Haematol. 2005 Oct;131(1):129-34
pubmed: 16173973
Lancet. 1986 Nov 22;2(8517):1198-201
pubmed: 2430154
Br J Haematol. 2008 Jul;142(1):119-25
pubmed: 18477043
Br J Haematol. 2006 Jun;133(5):570-8
pubmed: 16681647
Hemoglobin. 2013;37(4):325-32
pubmed: 23600469
Br J Haematol. 2002 Nov;119(2):567-71
pubmed: 12406102
PLoS One. 2008 May 07;3(5):e2095
pubmed: 18461136
N Engl J Med. 2004 Feb 26;350(9):886-95
pubmed: 14985486
N Engl J Med. 2017 Jul 20;377(3):305
pubmed: 28723338
Am J Hematol. 2011 Aug;86(8):705-8
pubmed: 21630312
N Engl J Med. 2011 Jul 7;365(1):44-53
pubmed: 21732836
Curr Opin Hematol. 2007 Sep;14(5):438-43
pubmed: 17934349
Afr J Med Med Sci. 1991 Mar;20(1):11-4
pubmed: 1905464
Br J Dermatol. 2008 Feb;158(2):339-44
pubmed: 18047512
Ann Trop Med Parasitol. 1983 Aug;77(4):411-9
pubmed: 6639186
Yale J Biol Med. 2001 May-Jun;74(3):179-84
pubmed: 11501714
Nat Med. 2002 Dec;8(12):1383-9
pubmed: 12426562
Pediatr Blood Cancer. 2017 Jul;64(7):
pubmed: 28371007
Clin Exp Hypertens. 2009 Feb;31(1):44-8
pubmed: 19172458
Br J Haematol. 2009 Nov;147(3):352-9
pubmed: 19694721
Blood. 2006 Mar 15;107(6):2279-85
pubmed: 16291595
Indian J Dermatol Venereol Leprol. 2005 Jan-Feb;71(1):50-2
pubmed: 16394367
Ann Dermatol. 2009 Feb;21(1):39-41
pubmed: 20548853
Am J Hematol. 2009 Sep;84(9):618-25
pubmed: 19610078
Br J Haematol. 1991 Sep;79(1):93-8
pubmed: 1716963
Blood. 1989 Sep;74(4):1403-8
pubmed: 2475188
Am J Hematol. 2016 Jan;91(1):22-30
pubmed: 26257201
Am J Hematol. 2010 Oct;85(10):831-3
pubmed: 20872960
Blood. 2010 Jun 3;115(22):4331-6
pubmed: 20233970
Am J Hematol. 2014 Jan;89(1):1-6
pubmed: 23963836
Ann Afr Med. 2010 Jan-Mar;9(1):1-4
pubmed: 20418641
East Afr Med J. 1992 Jul;69(7):366-9
pubmed: 1396190
Hematol Oncol Clin North Am. 2005 Oct;19(5):943-56, viii-ix
pubmed: 16214654
Adv Hematol. 2018 Dec 2;2018:6161270
pubmed: 30631363

Auteurs

Charles Antwi-Boasiako (C)

Department of Physiology, University of Ghana Medical School, Accra, Ghana.

Biree Andemariam (B)

New England Sickle Cell Institute, Division of Hematology-Oncology, Neag Comprehensive Cancer Center, UCONN Health, University of Connecticut, Farmington, CT, USA.

Raffaella Colombatti (R)

Clinic of Pediatric Hematology Oncology, Department of Women's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy.

Eugenia Vicky Asare (EV)

Department of Hematology, Korle-Bu Teaching Hospital, Accra, Ghana.

Crawford Strunk (C)

ProMedica Russell J. Ebeid Children's Hospital, Toledo, OH, USA.

Connie M Piccone (CM)

Pediatric Hematology/Oncology, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.

Deepa Manwani (D)

Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, USA.

Donna Boruchov (D)

Department of Pediatrics, Connecticut Children's Medical Center, Hartford, CT, USA.

Fatimah Farooq (F)

Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.

Rebekah Urbonya (R)

Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.

Samuel Wilson (S)

Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA.

Gifty Dankwah Boatemaa (GD)

Department of Physiology, University of Ghana Medical School, Accra, Ghana.

Silverio Perrotta (S)

Department of Women, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.

Laura Sainati (L)

Clinic of Pediatric Hematology Oncology, Department of Women's and Child Health, Azienda Ospedaliera-Università di Padova, Padova, Italy.

Angela Rivers (A)

Division of Pediatric Hematology/Oncology, University of Illinois- Chicago, Chicago, IL, USA.

Sudha Rao (S)

Department of Child Health, Korle Bu Teaching Hospital, Accra, Ghana.

William Zempsky (W)

Department of Pediatrics, Connecticut Children's Medical Center, Hartford, CT, USA.

Ivy Ekem (I)

Department of Haematology, University of Cape Coast, Cape Coast, Ghana.

Fredericka Sey (F)

Ghana Institute of Clinical Genetics, Korle Bu Teaching Hospital, Accra, Ghana.

Catherine Segbefia (C)

Department of Child Health, Korle Bu Teaching Hospital, University of Ghana Medical School, Accra, Ghana.

Baba Inusa (B)

Department of Pediatric Haematology, Evelina Children's Hospital, Guy's and St. Thomas NHS Trust, London, UK.

Immacolata Tartaglione (I)

Department of Women, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, Italy.

Andrew D Campbell (AD)

Division of Pediatric Hematology/Oncology, University of Michigan, Ann Arbor, MI, USA. acampbell@childrensnational.org.
Division of Hematology, Center for Cancer & Blood Disorders, Children's National Medical Center, George Washington University School of Medicine & Health Sciences, 111 Michigan Avenue NW, Washington, DC, 20010, USA. acampbell@childrensnational.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH